Hodgkin lymphoma


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

Hodg·kin lymphoma

 (hŏj′kĭn) or Hodg·kin's lymphoma (-kĭnz)
n.
A lymphoma typically characterized by the presence of Reed-Sternberg cells and producing symptoms that include enlarged lymph nodes and spleen, fever, night sweats, weight loss, and itching. Also called Hodgkin's disease.

[After Thomas Hodgkin (1798-1866), British physician.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
M2 EQUITYBITES-March 21, 2018-US FDA approves Adcetris for Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy
Two broad types of lymphomas are named as Hodgkin lymphoma and Non-Hodgkin lymphoma5.
-- Psoriasis of all severities was linked to a 3.5-fold increase in risk of cutaneous T-cell lymphoma, and severe psoriasis upped the associated risk of Hodgkin lymphoma by about 2.5 times, in a large, longitudinal, population-based cohort study.
In the present case report, we aim at describing an Iranian patient with langerhans cell histiocytosis followed by Hodgkin lymphoma. An informed consent was obtained from the patient for accessing his medical chart and the use of this data.
In 2009, 12,294 people were diagnosed with non-Hodgkin lymphoma and 1,852 people with Hodgkin lymphoma, while 4,452 people died from non-Hodgkin lymphoma in 2010 and 319 from Hodgkin lymphoma.
Researchers from 12 US HIV study groups and 2 Canadian groups combined their data to analyze trends in 2 AIDS cancers (Kaposi sarcoma and non-Hodgkin lymphoma) and 7 common non-AIDS cancers (anal cancer, lung cancer, Hodgkin lymphoma, liver cancer, malignant melanoma, cancer of the colon and rectum, and cancer of the mouth and throat).
The category of Hodgkin lymphoma includes classical Hodgkin lymphoma (CHL) and the less common nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).
Compared with extended-field irradiation, limited-field irradiation achieved similarly high cure rates in a new study of patients with early-stage Hodgkin lymphoma and diminished risks for late second malignancies and cardiovascular complications.
M2 PHARMA-January 11, 2019-Seattle Genetics Data Published On North American Subgroup Data from ECHELON-1 Phase 3 Clinical Trial of Adcetris in Newly Diagnosed Advanced Hodgkin Lymphoma
M2 EQUITYBITES-May 8, 2017-Merck receives EC approval for Keytruda to treat relapsed Hodgkin Lymphoma